retatrutide fda approval 2026 is getting a lot of attention, and for good reason. Early data looks promising, but it's still in clinical trials and not FDA-approved retatrutide clinical trials phase approval:

Perhaps most striking is its influence at the gene expression level: genome-wide profiling has shown that GHK-Cu affects approximately 4,000 human genes, shifting patterns associated with tissue damage and ageing toward profiles characteristic of healthier, younger tissue

Metabolomic analysis We used Biocrates AbsoluteIDQ p180 kit to analyze cardiac metabolites from female mice [Young ( n = 7), Old Con ( n = 8), and Old mAb ( n = 7)] with UPLC-MS/MS Xevo TQ, Waters, Pittsburgh, PA, USA) in the Einstein Stable Isotope and Metabolomics Core, according to the manufacturers instructions (BIOCRATES Life Sciences AG, Innsbruck, Austria)

& Hervas-martnez, C

Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fractio